We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITS
7576
Lite Strategy Inc
LITS
$32.8M
$34K ﹤0.01%
+813
New +$38.2K
GNMX
7577
DELISTED
Aevi Genomic Medicine Inc
GNMX
$34K ﹤0.01%
28,090
+10,752
+62% +$14.7K
CYTR
7578
DELISTED
CytRx Corp
CYTR
$34K ﹤0.01%
+20,118
New +$41.6K
ARLZ
7579
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$34K ﹤0.01%
+23,961
New +$39.3K
KODK icon
7580
CALL
Kodak
KODK
$822M
$33K ﹤0.01%
+10,500
New +$48.5K
TAOP icon
7581
Taoping
TAOP
$6.63M
$33K ﹤0.01%
12
+4
+50% +$10.2K
TST
7582
DELISTED
TheStreet, Inc.
TST
$33K ﹤0.01%
+2,251
New +$27.6K
CPAH
7583
DELISTED
Counterpath Corp
CPAH
$33K ﹤0.01%
+10,393
New +$26.8K
ARLZ
7584
PUT
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$33K ﹤0.01%
23,000
+1,700
+8% +$2.79K
CLNE icon
7585
CALL
Clean Energy Fuels
CLNE
$427M
$32K ﹤0.01%
+15,800
New +$34.9K
OTLK icon
7586
Outlook Therapeutics
OTLK
$183M
$32K ﹤0.01%
+154
New +$31.9K
PDS
7587
CALL
Precision Drilling
PDS
$999M
$32K ﹤0.01%
+525
New +$28.8K
PZG icon
7588
Paramount Gold Nevada
PZG
$96.1M
$32K ﹤0.01%
24,356
+12,446
+105% +$15.8K
RAND icon
7589
Rand Capital
RAND
$32K ﹤0.01%
+1,192
New +$31.5K
TNK icon
7590
Teekay Tankers
TNK
$2.75B
$32K ﹤0.01%
+2,842
New +$34.9K
NM
7591
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$32K ﹤0.01%
+2,700
New +$41.2K
MCEP
7592
DELISTED
Mid-Con Energy Partners, LP
MCEP
$32K ﹤0.01%
+1,340
New +$29.1K
ECT
7593
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$32K ﹤0.01%
+14,748
New +$33.5K
PDS
7594
PUT
Precision Drilling
PDS
$999M
$31K ﹤0.01%
505
-475
-48% -$26K
SBET icon
7595
Sharplink Inc
SBET
$1.29B
$31K ﹤0.01%
+61
New +$31.7K
SHIP icon
7596
Seanergy Maritime Holdings
SHIP
$379M
$31K ﹤0.01%
+12
New +$31.1K
VSTM icon
7597
PUT
Verastem
VSTM
$510M
$31K ﹤0.01%
+833
New +$37.6K
WLB
7598
DELISTED
Westmoreland Coal Company
WLB
$31K ﹤0.01%
+25,423
New +$43.7K
CTIC
7599
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$31K ﹤0.01%
+11,600
New +$34K
CTIC
7600
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$31K ﹤0.01%
+11,418
New +$33.5K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.